Literature DB >> 23277764

Power of an effective clinical conversation: improving accrual onto clinical trials.

Linda K Parreco1, Rhonda W DeJoice, Holly A Massett, Rose Mary Padberg, Sona S Thakkar.   

Abstract

The National Cancer Institute (NCI) is actively transforming clinical trials to revitalize the clinical trials system and improve patient accrual. For more than 30 years, NCI has provided information and communication resources about cancer clinical trials. The Institute supports a clinical trials Web site (www.cancer.gov/clinicaltrials) that receives nearly a half million page views a month. In addition, NCI's Cancer Information Service (800-4-CANCER, chat and e-mail) responds to 1,750 clinical trial inquiries every month. Although these numbers suggest that a high volume of clinical trial information is being exchanged between NCI, the public, and providers, most patients decide whether to participate in clinical trials during the patient-provider interaction.

Entities:  

Mesh:

Year:  2012        PMID: 23277764      PMCID: PMC3439227          DOI: 10.1200/JOP.2011.000478

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  30 in total

Review 1.  Factors influencing inclusion of patients with malignancies in clinical trials.

Authors:  Caroline Tournoux; Sandrine Katsahian; Sylvie Chevret; Vincent Levy
Journal:  Cancer       Date:  2006-01-15       Impact factor: 6.860

2.  Implementing clinical trials: a review of the attributes of exemplary clinical trial sites.

Authors:  Allison R Baer; Gary Cohen; Dee Anna Smith; Robin Zon
Journal:  J Oncol Pract       Date:  2010-11       Impact factor: 3.840

3.  AccrualNet: Addressing Low Accrual Via a Knowledge-Based, Community of Practice Platform.

Authors:  Holly A Massett; Linda K Parreco; Rose Mary Padberg; Ellen S Richmond; Marie E Rienzo; Colleen E Ryan Leonard; Whitney Quesenbery; H William Killiam; Lenora E Johnson; David M Dilts
Journal:  J Oncol Pract       Date:  2011-10-21       Impact factor: 3.840

4.  Strategic physician communication and oncology clinical trials.

Authors:  T L Albrecht; C Blanchard; J C Ruckdeschel; M Coovert; R Strongbow
Journal:  J Clin Oncol       Date:  1999-10       Impact factor: 44.544

5.  Improving informed consent: suggestions from parents of children with leukemia.

Authors:  Michelle L Eder; Amy D Yamokoski; Peter W Wittmann; Eric D Kodish
Journal:  Pediatrics       Date:  2007-04       Impact factor: 7.124

6.  Factors that influence Spanish- and English-speaking participants' decision to enroll in cancer randomized clinical trials.

Authors:  Lee Ellington; Stephanie Wahab; Shadi Sahami Martin; Rosemary Field; Kathleen H Mooney
Journal:  Psychooncology       Date:  2006-04       Impact factor: 3.894

7.  Discussing randomised clinical trials of cancer therapy: evaluation of a Cancer Research UK training programme.

Authors:  V Jenkins; L Fallowfield; I Solis-Trapala; C Langridge; V Farewell
Journal:  BMJ       Date:  2005-02-10

Review 8.  A systematic review highlights threats to validity in studies of barriers to cancer trial participation.

Authors:  Debra Fayter; Catriona McDaid; Alison Eastwood
Journal:  J Clin Epidemiol       Date:  2007-07-16       Impact factor: 6.437

9.  Diversity of participants in clinical trials in an academic medical center: the role of the 'Good Study Patient?'.

Authors:  Galen Joseph; Daniel Dohan
Journal:  Cancer       Date:  2009-02-01       Impact factor: 6.860

10.  Enduring impact of communication skills training: results of a 12-month follow-up.

Authors:  L Fallowfield; V Jenkins; V Farewell; I Solis-Trapala
Journal:  Br J Cancer       Date:  2003-10-20       Impact factor: 7.640

View more
  3 in total

1.  Refusal to participate in heart failure studies: do age and gender matter?

Authors:  Jordan M Harrison; Miyeon Jung; Terry A Lennie; Debra K Moser; Dean G Smith; Sandra B Dunbar; David L Ronis; Todd M Koelling; Bruno Giordani; Penny L Riley; Susan J Pressler
Journal:  J Clin Nurs       Date:  2016-02-23       Impact factor: 3.036

2.  Modeling and validating Bayesian accrual models on clinical data and simulations using adaptive priors.

Authors:  Yu Jiang; Steve Simon; Matthew S Mayo; Byron J Gajewski
Journal:  Stat Med       Date:  2014-11-06       Impact factor: 2.373

3.  The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.

Authors:  Andrea M Denicoff; Worta McCaskill-Stevens; Stephen S Grubbs; Suanna S Bruinooge; Robert L Comis; Peggy Devine; David M Dilts; Michelle E Duff; Jean G Ford; Steven Joffe; Lidia Schapira; Kevin P Weinfurt; Margo Michaels; Derek Raghavan; Ellen S Richmond; Robin Zon; Terrance L Albrecht; Michael A Bookman; Afshin Dowlati; Rebecca A Enos; Mona N Fouad; Marjorie Good; William J Hicks; Patrick J Loehrer; Alan P Lyss; Steven N Wolff; Debra M Wujcik; Neal J Meropol
Journal:  J Oncol Pract       Date:  2013-10-15       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.